FDA Inspection 1239092 — Grifols Biologicals LLC
The FDA completed an inspection of Grifols Biologicals LLC on September 10, 2024 in City Of Industry, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- City Of Industry, CA (United States)